Advanced search
Publication Cover
Journal of Medical Economics Volume 23, 2020 - Issue 1
Submit an article Journal homepage
5,457
Views
14
CrossRef citations to date
0
Altmetric
Oncology

Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States

Alison StopeckDivision of Hematology/Oncology, Stony Brook Cancer Center, Stony Brook, NY, USA; Correspondence[email protected]
,
Adam BrufskyDivision of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA, USA;
,
Lisa KennedyEpiphany, Los Angeles, CA, USA;
,
Sumi BhattaGlobal Health Economics, Amgen Inc, Thousand Oaks, CA, USA
,
Debajyoti BhowmikGlobal Health Economics, Amgen Inc, Thousand Oaks, CA, USA
,
Jacqueline BuchananGlobal Health Economics, Amgen Inc, Thousand Oaks, CA, USA
,
Nicolas DespiegelGlobal Health Economics, Amgen Inc, Thousand Oaks, CA, USA
&
Guy HechmatiGlobal Health Economics, Amgen Inc, Thousand Oaks, CA, USA
 show all
Pages 37-47 | Received 17 Jun 2019, Accepted 30 Jul 2019, Published online: 26 Aug 2019

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mohamad Moussa, Athanasios Papatsoris, Despoina Sryropoulou, Mohamed Abou Chakra, Athanasios Dellis & Lazaros Tzelves. (2021) A pharmacoeconomic evaluation of pharmaceutical treatment options for prostate cancer. Expert Opinion on Pharmacotherapy 22:13, pages 1685-1728.
Read now
Javier Garcia Perlaza, Rima Aziziyeh, Anna Zhou, Vitor De Sousa Barbosa, Jenny Amaya, Joaquin Caporale, Monica Elena Alva, Juan Forero, Straus Tanaka, Gaurav Suri & David Garcia. (2021) The burden of skeletal-related events in four Latin American countries: Argentina, Brazil, Colombia, and Mexico. Journal of Medical Economics 24:1, pages 983-992.
Read now

Articles from other publishers (12)

А.А. Кабанова, С.А. Кабанова, К.С. Воднев & М.А. Леута. (2023) Стоматологическая помощь пациентам с медикаментозным остеонекрозом челюстей. Dentist. Minsk:1 (48), pages 36-41.
Crossref
Katharina Sommer, Svenja Wulf & Julia Gallwas. (2023) Brust- und gynäkologische Tumoren – medikamentöse Therapie ossärer Metastasen. Frauenheilkunde up2date 17:01, pages 65-82.
Crossref
Franco Lumachi & Stefano M. M. Basso. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 23 .
C. Luo, S.-X. Qin, Q.-Y. Wang, Y.-F. Li, X.-L. Qu, C. Yue, L. Hu, Z.-F. Sheng, X.-B. Wang & X.-M. Wan. (2022) Cost-effectiveness analysis of five drugs for treating postmenopausal women in the United States with osteoporosis and a very high fracture risk. Journal of Endocrinological Investigation 46:2, pages 367-379.
Crossref
Salvatore L. Ruggiero, Thomas B. Dodson, Tara Aghaloo, Eric R. Carlson, Brent B. Ward & Deepak Kademani. (2022) American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update. Journal of Oral and Maxillofacial Surgery 80:5, pages 920-943.
Crossref
Eric Schwartz, Zachery Reichert & Catherine Van Poznak. (2022) Pharmacologic management of metastatic bone disease. Bone 158, pages 115735.
Crossref
Charles L. Shapiro. (2021) Bone-modifying Agents (BMAs) in Breast Cancer. Clinical Breast Cancer 21:5, pages e618-e630.
Crossref
Tilman D Rachner, Robert Coleman, Peyman Hadji & Lorenz C Hofbauer. (2021) Individualized Bone‐Protective Management in Long‐Term Cancer Survivors With Bone Metastases. Journal of Bone and Mineral Research 36:10, pages 1906-1913.
Crossref
Deepak Dabkara. (2021) Cancer Treatment–Induced Bone Loss and Role of Denosumab in Nonmetastatic Prostate Cancer: A Narrative Review. Indian Journal of Medical and Paediatric Oncology 42:03, pages 240-246.
Crossref
Fränce Hardtstock, Zeki Kocaata, Thomas Wilke, Axel Dittmar, Marco Ghiani, Vasily Belozeroff, David J. Harrison, Ulf Maywald & Hans Tesch. (2021) Healthcare resource utilization and associated cost of patients with bone metastases from solid tumors who are naïve to bone-targeting agents: a comparative analysis of patients with and without skeletal-related events. The European Journal of Health Economics 22:2, pages 243-254.
Crossref
Thomas H. Beckham, T. Jonathan Yang, Daniel Gomez & C. Jillian Tsai. (2020) Metastasis-directed therapy for oligometastasis and beyond. British Journal of Cancer 124:1, pages 136-141.
Crossref
Chuo Luo, ShuXia Qin, QinYi Wang, YongFang Li, XiaoLi Qu, Chun Yue, Li Hu, sheng zhifeng & XiaoMin Wan. (2022) Cost-Effectiveness Analysis of Five Drugs for Treating Postmenopausal Women in the United States with Osteoporosis and a Very High Fracture Risk. SSRN Electronic Journal.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.